Using antibody TMEM239, we used tissues from a 78-year-old individual with PSP and a 90-year-old individual with AD to investigate the presence of TMEM106B inclusions in central nervous system regions other than the frontal cortex (Fig. 2). Here, TMEM106B is linked to supranuclear palsy, progressive, 1.